Orphazyme A/S – LSE:0CUM.L

Founder-led company

Orphazyme A/S stock price today

DKK 17.02
+16.03
+1626.16%
Financial Health
0
1
2
3
4
5
6
7
8
9

Orphazyme A/S stock price monthly change

-21.12%
month

Orphazyme A/S stock price quarterly change

-50.69%
quarter

Orphazyme A/S stock price yearly change

-50.69%
year

Orphazyme A/S key metrics

Market Cap
 34.81K
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -744.24
Revenue
 N/A
EBITDA
 390
Income
 -26.04K
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Orphazyme A/S stock price history

Orphazyme A/S stock forecast

Orphazyme A/S financial statements

Profit Margin

Orphazyme A/S (LSE:0CUM.L): Profit margin
Mar 2023 0 -6.39K
Jun 2023 0 -6.39K
Sep 2023 0 -6.63K
Dec 2023 0 -6.63K
0CUM.L income statement history

Debt to Assets

Orphazyme A/S (LSE:0CUM.L): Debt to assets
Mar 2023 36181 7.29K 20.17%
Jun 2023 36181 7.29K 20.17%
Sep 2023 19312 5.07K 26.25%
Dec 2023 19312 5.07K 26.25%
0CUM.L balance sheet history

Cash Flow

Orphazyme A/S (LSE:0CUM.L): Cash Flow
Mar 2023 -6.06K 0 0
Jun 2023 -6.06K 0 0
Sep 2023 -3.94K -3.47K -342
Dec 2023 -3.94K -3.47K -342
0CUM.L cash flow history

Orphazyme A/S alternative data

Orphazyme A/S
Employees

Orphazyme A/S (LSE:0CUM.L): Employee count
Aug 2023 1
Sep 2023 1
Oct 2023 1
Nov 2023 1
Dec 2023 1
Jan 2024 1
Feb 2024 1
Mar 2024 1
Apr 2024 1
May 2024 1
Jun 2024 1
Jul 2024 1

Orphazyme A/S other data

Orphazyme A/S
Patents

Patent
Application
Filling date: 10 Mar 2022 Issue date: 1 Sep 2022
Application
Filling date: 23 Dec 2021 Issue date: 7 Jul 2022
Application
Filling date: 12 Jan 2022 Issue date: 5 May 2022
Grant
Filling date: 20 May 2020 Issue date: 22 Feb 2022
Grant
Filling date: 23 Mar 2020 Issue date: 25 Jan 2022
Grant
Filling date: 27 Nov 2019 Issue date: 29 Jun 2021
Application
Filling date: 30 Nov 2020 Issue date: 24 Jun 2021
Application
Filling date: 28 May 2019 Issue date: 3 Jun 2021
Grant
Filling date: 10 Apr 2017 Issue date: 26 Jan 2021
Application
Filling date: 20 May 2020 Issue date: 17 Sep 2020
0CUM.L patents

Orphazyme A/S
Executives

Insider Compensation
Ms. Kim Stratton Chief Executive Officer
Dr. Thomas Kirkegaard Jensen Ph.D. Co-Founder & Chief Scientific Officer
Mr. Anders Fink Vadsholt M.B.A., M.Sc., MBA Chief Financial Officer
Dr. Thomas Blaettler Chief Medical Officer

Frequently Asked Questions (FAQ)

  • What's the price of Orphazyme A/S stock today?

    One share of Orphazyme A/S stock can currently be purchased for approximately $17.02.

  • When is Orphazyme A/S's next earnings date?

    Unfortunately, Orphazyme A/S's (0CUM.L) next earnings date is currently unknown.

  • Does Orphazyme A/S pay dividends?

    No, Orphazyme A/S does not pay dividends.

  • How much money does Orphazyme A/S make?

    Orphazyme A/S has a market capitalization of 34.81K.

  • What is Orphazyme A/S's stock symbol?

    Orphazyme A/S is traded on the LSE under the ticker symbol "0CUM.L".

  • What is Orphazyme A/S's primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Orphazyme A/S?

    Shares of Orphazyme A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Orphazyme A/S's key executives?

    Orphazyme A/S's management team includes the following people:

    • Ms. Kim Stratton Chief Executive Officer
    • Dr. Thomas Kirkegaard Jensen Ph.D. Co-Founder & Chief Scientific Officer
    • Mr. Anders Fink Vadsholt M.B.A., M.Sc., MBA Chief Financial Officer
    • Dr. Thomas Blaettler Chief Medical Officer

  • Is Orphazyme A/S founder-led company?

    Yes, Orphazyme A/S is a company led by its founder Dr. Thomas Kirkegaard Jensen Ph.D..

  • How many employees does Orphazyme A/S have?

    As Jul 2024, Orphazyme A/S employs 1 workers.

  • When Orphazyme A/S went public?

    Orphazyme A/S is publicly traded company for more then 7 years since IPO on 12 Feb 2018.

  • What is Orphazyme A/S's official website?

    The official website for Orphazyme A/S is orphazyme.com.

  • How can i contact Orphazyme A/S?

    Orphazyme A/S can be reached via phone at +45 39 17 82 72.

Orphazyme A/S company profile:

Orphazyme A/S

orphazyme.com
Exchange:

LSE

Full time employees:

1

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

+45 39 17 82 72
Ole MaalOees Vej 3
Copenhagen, 2200

:
ISIN: DK0060910917
CUSIP: K76533114